DRIFTS Method Applied to Quantification of Cephalexin in Powder for Oral Suspension - A Process Analytical Technology (PAT) Approach

被引:0
作者
Okamoto, Rogerio T. [1 ]
Ghisleni, Daniela D. M. [1 ]
Lourenco, Felipe R. [1 ]
Pinto, Terezinha de J. A. [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, BR-05508000 Sao Paulo, SP, Brazil
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2015年 / 34卷 / 06期
关键词
cephalexin; diffuse reflectance infrared fourier transformation spectroscopy (DRIFTS); partial least square (PLS) regression; process analytical technology (PAT); LIQUID-CHROMATOGRAPHIC METHOD; SPECTROSCOPY; ANTIBIOTICS; VALIDATION; DISCOVERY; ASSAY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Conventional methods are labor intensive, time spending and do not allow real time analysis. Infrared spectroscopic is an alternative to conventional methods, with several advantages including its application in process analytical technology (PAT). The aim of the paper was to develop a diffuse reflectance infrared spectroscopic (DRIFTS) method for cephalexin analysis in powder for suspension. Calibration and validation samples were prepared by mixing cephalexin with a placebo preparation in several levels, containing from 80 to 130% of labeled content of commercial products. Method validation was assess by precision (repeatability RSD = 2.2 %, and intermediate precision RSD = 3.0%) and accuracy (mean recovery = 98.3%). In addition, commercial samples were analyzed using DRIFTS, HPLC, and bioassay. According to the results of equivalence test, DRIFTS provides similar results to those obtained using HPLC and Bioassay. Therefore, the DRIFTS may be employed in PAT by pharmaceutical industry.
引用
收藏
页码:1070 / 1075
页数:6
相关论文
共 26 条
[1]  
Allo-Martinez L., 1998, ANAL CHIM ACTA, V370, P115
[2]  
[Anonymous], 2010, FARMACOPEIA BRASILEI, P764
[3]  
[Anonymous], 2012, USP35NF30, V2, P2587
[4]   Development and validation of a near infrared method for the analytical control of a pharmaceutical preparation in three steps of the manufacturing process [J].
Blanco, M ;
Coello, J ;
Iturriaga, H ;
Maspoch, S ;
Pou, N .
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 2000, 368 (05) :534-539
[5]   Introduction to multivariate calibration in analytical chemistry [J].
Brereton, RG .
ANALYST, 2000, 125 (11) :2125-2154
[6]   Antibiotics in the clinical pipeline in 2011 [J].
Butler, Mark S. ;
Cooper, Matthew A. .
JOURNAL OF ANTIBIOTICS, 2011, 64 (06) :413-425
[7]  
Chambers H.F., 2006, BASES FARMACOLOGICAS
[8]   Analysis of cephalosporin antibiotics [J].
El-Shaboury, Salwa R. ;
Saleh, Gamal A. ;
Mohamed, Fardous A. ;
Rageh, Azza H. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (01) :1-19
[9]  
FDA US Food and Drug Administration, 2004, Guidance for industry, PAT-A framework for innovative pharmaceutical development, manufacturing and quality assurance
[10]   ANTIBIOTICS: THERAPEUTIC IMPORTANCE AND PERSPECTIVES FOR THE DISCOVERY AND DEVELOPMENT OF NEW AGENTS. [J].
Guimaraes, Denise Oliveira ;
Momesso, Luciano da Silva ;
Pupo, Monica Tallarico .
QUIMICA NOVA, 2010, 33 (03) :667-679